Versiguard Rabies vet.
Active substance
ATC code
Species
Dogs, cats, cattle, pigs, sheep, goats, horses and ferrets.
Indications
For the active immunisation of dogs, cats, cattle, pigs, sheep, goats, horses and ferrets (12 weeks of age and older) to prevent infection and mortality caused by rabies virus.
Onset of immunity:
14–21 days after primary vaccination.
Duration of immunity:
Dogs: three years following the primary vaccination course.
Cats, cattle, pigs, sheep, goats, horses and ferrets:
one year after primary vaccination, and two years after booster vaccinations.
Dose to be administered and administration route
Dogs: administer by subcutaneous injection.
All other species: administer by subcutaneous or intramuscular injection.
Shake the vial before use.
Dosage:
A single dose of 1 ml is sufficient irrespective of age, weight or animal species.
Primary vaccination scheme:
Animals of all target species can be vaccinated from 12 weeks of age.
Primary vaccination is with a single dose of vaccine.
Re-vaccination scheme:
Dogs: a single dose of Versiguard Rabies should be given every 3 years. Antibody titres drop over the course of the 3-year duration of immunity, although dogs are protected when challenged. In case of travelling to risk areas or outside the UK, veterinary surgeons may wish to give additional rabies vaccinations to ensure that the vaccinated dogs have an antibody titre ≥ 0.5 IU/ml, which is generally regarded as sufficiently protective and that they meet the travel test requirements (antibody titres ≥ 0.5 IU/ml).
Cats, cattle, pigs, sheep, goats, horses and ferrets: animals should be revaccinated with one dose of vaccine 1 year after primary vaccination.
After the first booster vaccination (administered 1 year after primary vaccination), animals should be revaccinated every 2 years with one dose of vaccine.
Adverse reactions
Dogs:
|
Very rare (<1 animal / 10,000 animals treated, including isolated reports): |
Injection site swelling1 Hypersensitivity reaction2 |
1Transient, following subcutaneous administration which may reach up to 10 mm in diameter and in rare cases be associated with mild discomfort. Usually resolves within 10 days.
2Appropriate treatment should be administered without delay.
Cats, cattle, pigs, sheep, goats, horses and ferrets:
|
Very rare (<1 animal / 10,000 animals treated, including isolated reports): |
Injection site pain1, Injection site swelling2 Hypersensitivity reaction3 |
1Mild and associated with injection site swelling.
2Transient.
- following intramuscular administration may reach up to 2 cm in diameter and usually resolves within 7 days.
- following subcutaneous administration may reach up to 10 mm in diameter and usually resolves within 10 days. In rare cases may be associated with mild discomfort.
3Appropriate treatment should be administered without delay.
Reporting adverse events is important. It allows continuous safety monitoring of a veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to either the marketing authorisation holder or the national competent authority via the national reporting system. See also section 16 of the package leaflet for contact details.
